June Newsmakers Including ASCO Coverage

ASCO 2019 Coverage

Yousuf Zafar, MD, MA, one of three plenary discussants at ASCOWhat's Happening at ASCO 2019? (Medscape)
Features Yousuf Zafar, MD, MA

LISTEN: High Deductibles Push Millions Of Americans To Make 'Difficult Sacrifices' For Health Care (WBUR)
Features Yousuf Zafar, MD, MA

Soaring insurance deductibles and high drug prices hit sick Americans with a ‘double whammy’ (Los Angeles Times)
Features Yousuf Zafar, MD, MA

WATCH: The Quality and Completeness of Data (Oncology Tube)
Features Yousuf Zafar, MD, MA

ACA Medicaid Expansion Reduces Disparities in Cancer Care (Medscape)
Features Yousuf Zafar, MD, MA

Medicaid Expansion Eliminated Racial Disparities in Timeliness of Treatment Between Black and White Patients With Advanced Cancer (Cancer Therapy Advisor)
Features Yousuf Zafar, MD, MA

ASCO 2019: 40-50 percent response rate for brigatinib after other next-gen ALK inhibitors (University of Colorado Anschutz Medical Campus)
Features Thomas Stinchcombe, MD

Brigatinib Shows Activity Following Other ALK TKIs in ALK+ NSCLC (Targeted Oncology)
Thomas Stinchcombe, MD

GU oncologists Tian Zhang, MD, and Daniel George, MD, at ASCO 2019 Poster SessionNIH Precision Medicine Trial Releases Cancer Study Results (Health IT Analytics & Medical Express)
Features April Salama, MD

ASCO Poster Rounds: Provenge Benefits Black Prostate Ca Patients Most (Medpage Today)
Alexandra Mara, MD, and Susan Halabi, PhD

WATCH: Dr. Daniel George on the Treatment Landscape for RCC (Cancer Network)
Features Daniel George, MD

Breast oncologist Cary Anders, MD, being interviewed at ASCO 2019WATCH: S-TRAC Study Data: Took 3 Years To Complete, Disease Free Survival Rate Improved By 24With 1 Year Of Adjuvant Sunitinib (Oncology Tube)
Features Daniel George, MD

WATCH: Tian Zhang, MD, shares thoughts on the PDIGREE trial in metastatic, untreated RCC (OBR)

ASCO 2019: ARCHES: Efficacy of Androgen Deprivation Therapy with Enzalutamide or Placebo in Metastatic Hormone-sensitive Prostate Cancer (Uro Today)
Features Andrew Armstrong, MD

ASCO 2019: Enzalutamide versus Enzalutamide, Abiraterone, and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Alliance A031201(Uro Today)
Features Andrew Armstrong, MD, and Susan Halabi, PhD

ASCO 2019: Overall Survival of African-American and Caucasian Men Who Received Sipuleucel-T for Metastatic Castration-resistant Prostate Cancer: Final PROCEED Analysis (Uro Today)
Features Andrew Armstrong, MD

Dr. Anders on Abemaciclib in HR+ Breast Cancer With Brain Metastases (OncLive)

Abemaciclib stabilizes brain metastases in breast cancer subtype (Healio)
Features Cary Anders, MD

Improving Response to Front-Line Therapy in Advanced Ovarian Cancer (MedPage Today)
References Angeles Alvarez Secord, MD

More In the News

Opinion | People with chronic illness are not problems to be solved. We’re people to be loved. (The Washington Post)
Features Kate Bowler, PhD

Dreading a Colonoscopy? Other Tests Are Just as Effective for Colon Cancer (Healthline)
Features Deborah Fisher, MD, MHS

The cost of cancer: 25% of survivors face financial hardship, report finds (CNN)
Features Rachel Greenup, MD

Cancer patients, survivors 'rejuvenated' at Duke Survivorship Day (WTVD)

Durham woman spreads hope while living with pancreatic cancer (WRAL)
Features DCI patient and Kevin Shah, MD

A Shortage Of End-Of-Life Doctors Is Coming (Forbes)
Features Arif Kamal, MD

Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer (Uro Today)
Features Brant Inman, MD; Yingqi Wang, BS; Andrew Chang, MD; Wei Phin Tan, MD; Joseph J Fantony, MD; Ajay Gopalakrishna, BS; Gregory J Barton, MD; Paul E Wischmeyer, MD; Rajan T Gupta, MD

How prostate cancer cells mimic bone when they metastasize (Science Daily)
Features Andrew Armstrong, MD

Report: Role of Surgery Limited in Advanced Pancreatic Ductal Adenocarcinoma (Clinical Oncology News)
Features Peter Allen, MD

Second Annual Victory Ride to Cure Cancer Raises More Than $230,000 for Cancer Research (Oncology Nursing News)
Features Duke Cancer Institute

Myeloma Treatment Landscape Continues to Change (Oncology Nursing News)
Features Cristina Gasparetto, MD

Encouraging Trend: New Evidence Says Rates Of Cancer Deaths Are On The Decline (Survivor.Net)
Features Michael Kastan, MD, PhD

Combination Therapies Offer Newer Options for CLL Treatment (Cure)
Features Danielle Brander, MD

Genomic Testing Linked With Lower Health Care Costs in High-Risk Breast Cancer (Journal of Clinical Pathways)
Features Michaela Dinan, PhD

In TEDMED Talk, Kate Bowler Talks About Life Following Her Diagnosis With Stage 4 Cancer (Duke Today)

Drug makes tumors more susceptible to chemo (MIT)
Features Pei Zhou, PhD; Jiyong Hong, PhD; and Javaria Najeeb

Overdiagnosis and the Future of Cancer Medicine (Duke Today)
Features Marc Ryser, PhD

A Molecular Glue to Overcome Cancer Drug Resistance? (Duke Today)
Features Pei Zhou, PhD

Duke biomedical engineering professor wins social impact award (WRAL Techwire)
Nimmi Ramanujam, PhD

2019 Distinguished Faculty Award - Donald McDonnell, PhD (Duke University School of Medicine)

Francesca Rigiroli, MD, awarded a research fellowship promoted by the Bracco Foundation (Duke Radiology)

Neurology and Women's Health: Brain Tumors (Department of Neurology)
Features Katy Peters, MD